Methodological quality of pharmacogenetic studies: Issues of concern

Statistics in Medicine

Volumn 27, Issue 30, 2008, Pages 6547-6569

  Jorgensen, Andrea L ^a   Williamson, Paula R ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Compliance; Genetic association studies; Methodological quality; Outcome reporting bias; Pharmacogenetics; Systematic reviews

Indexed keywords

ARTICLE; EMPIRICAL RESEARCH; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN GENOME; METHODOLOGY; PHARMACOGENETICS; REPRODUCIBILITY; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; STANDARD; STATISTICAL MODEL;

EMPIRICAL RESEARCH; GENETIC VARIATION; GENOME, HUMAN; GENOTYPE; HUMANS; MODELS, STATISTICAL; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SAMPLE SIZE;

EID: 63249115756     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3420     Document Type: Article

References (50)

1. International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 2001; 409(6822):860.
2. The International HapMap, C. A haplotype map of the human genome. Nature 2005; 437(7063):1299.
3. Three views of genetics: the enthusiast, the visionary, the sceptic. British Medical Journal 2001; 322(7293):1016.
4. Bioethics NCO. Pharmacogenetics: Ethical Issues. 2003.
5. Ryan SG. Regression to the truth: replication of association in pharmacogenetic studies. Pharmacogenomics 2003; 4(2):201-207.
6. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. The Lancet 2003; 361(9357):567.
7. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genetics in Medicine 2002; 4(2):45-61.
8. Balding DJ. A tutorial on statistical methods for population association studies. Nature Reviews Genetics 2006; 7(10):781.
9. Bogardus Jr ST, Concato J, Feinstein AR. Clinical epidemiological quality in molecular genetic research: the need for methodological standards. Journal of the American Medical Association 1999; 281(20):1919-1926.
10. Colhoun HM, McKeigue PM, Smith GD. Problems of reporting genetic associations with complex outcomes. The Lancet 2003; 361(9360):865.
11. David NC, Robert LN, Michael K. Proposed guidelines for papers describing DNA polymorphism-disease associations. Human Genetics 2002; 110(3):207.
12. Freimer NB, Sabatti C. Guidelines for association studies in human molecular genetics. Human Molecular Genetics 2005; 14(17):2481-2483.
13. Hattersley AT, McCarthy MI. What makes a good genetic association study? The Lancet 2005; 366(9493):1315.
14. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nature Genetics 2001; 29(3):306.
15. Little J, Bradley L, Bray MS, Clyne M, Dorman J, Ellsworth DL, Hanson J, Khoury MJ, Lau J, O'Brien TR, Rothman N, Stroup D, Taioli E, Thomas D, Vainio H, Wacholder S, Weinberg C. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. American Journal of Epidemiology 2002; 156(4):300-310.
16. Rebbeck TR, Martínez ME, Sellers TA, Shields PG, Wild CP, Potter JD. Genetic variation and cancer: improving the environment for publication of association studies. Cancer Epidemiology Biomarkers and Prevention 2004; 13(12):1985-1986.
17. Romero R, Kuivaniemi H, Tromp G, Olson J. The design, execution, and interpretation of genetic association studies to decipher complex diseases. American Journal of Obstetrics and Gynecology 2002; 187(5):1299.
18. Weiss SEA. Case-control association studies in pharamacogenetics. The Pharamcogenomics Journal 2001; 1: 157-158.
19. Freidlin B, Zheng G, Li ZH, Gastwirth JL. Trend tests for case-control studies of genetic markers: power, sample size and robustness. Human Heredity 2002; 53:146-152.
20. National Center for Biotechnology Information. Available from: http://www.ncbi.nlm.nih.gov/.
21. HapMap Database. Available from: http://www.hapmap.org/.
22. Hutton JL, Williamson PR. Bias in meta-analysis due to outcome variable selection within studies. Journal of the Royal Statistical Society, Series C-Applied Statistics 2000; 49(3):359-370.
23. Davies SM. Pharmacogenetics, pharmacogenomics and personalized medicine: are we there yet? Hematology American Society of Hematology Educational Program 2006; 1:111-117.
24. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B (Methodological) 1995; 57(1):289-300.
25. Kelsey JL, Whitemore AS, Evans AS, Thompson WD. Methods in Observational Epidemiology. Oxford University Press: U.S.A., 1996. ISBN 978-0195083774.
26. Holford TR, Windemuth A, Ruano G. Designing physiogenomic studies. Pharmacogenomics 2006; 7(2):157-158.
27. Wadelius M, Pirmohamed M. Pharmacogenetics of warfarin: current status and future challenges. Pharmacogenomics Journal 2006; 7(2):99.
28. Eland IA, Belton KJ, van Grootheest AC, Meiners AP, Rawlins MD, Stricker BH. Attitudinal survey of voluntary reporting of adverse drug reactions. British Journal of Clinical Pharmacology 1999; 48(4):623-627.
29. Oliphant A, Barker DL, Stuelpnagel JR, Chee MS. BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. Biotechniques 2002; June Suppl.:56-58, 60-61.
30. Van Buuren S, Oudshoorn K. Flexible multivariate imputation by MICE. TNO Prevention and Health Report, October 1999. ISBN 90-6743-623-2.
31. Schafer JL. Analysis of Incomplete Multivariate Data. Chapman & Hall/CRC: 1997. ISBN 978-0412040610.
32. Li Q, Yu K. Improved correction for population stratification in genome-wide association studies by identifying hidden population structures. Genetic Epidemiology 2008; 32(3):215-226.
33. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics 2007; 81(3):559-575.
34. Knowler WC, Williams RC, Pettitt DJ, Steinberg AG. Gm3;5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture. American Journal of Human Genetics 1988; 43(4):520-526.
35. Pato CN, Macciardi F, Pato MT, Verga M, Kennedy JL. Review of the putative association of dopamine D2 receptor and alcoholism: a meta-analysis. American Journal of Medical Genetics 1993; 48(2):78-82.
36. Gelernter J, Goldman D, Risch N. The A1 allele at the D2 dopamine receptor gene and alcoholism: a reappraisal. The Journal of the American Medical Association 1993; 269(13):1673-1677.
37. Morton NE, Collins A. Tests and estimates of allelic association in complex inheritance. Proceedings of the National Academy of Sciences 1998; 95(19):11389-11393.
38. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. The Lancet 2003; 361(9357):598.
39. Pritchard JK, Rosenberg NA. Use of unlinked genetic markers to detect population stratification in association studies. American Journal of Human Genetics 1999; 65(1):220-228.
40. Devlin B, Roeder K, Wasserman L. Genomic control, a new approach to genetic-based association studies. Theoretical Population Biology 2001; 60(3):155.
41. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000; 155(2):945-959.
42. Setakis E, Stirnadel H, Balding DJ. Logistic regression protects against population structure in genetic association studies. Genome Research 2006; 16(2):290-296.
43. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nature Genetics 2006; 38(8):904-949.
44. Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992; 48(2):361-372.
45. Warnes G. R: Genetics Package. 2007 [cited 2008 29/4/2008]; Available from: http://cran.r-project.org/web/packages/genetics/.
46. Williamson PR, Gamble C. Identification and impact of outcome selection bias in meta-analysis. Statistics in Medicine 2005; 24(10):1547-1561.
47. Contopoulos-Ioannidis DG, Alexiou GA, Gouvias TC, Ioannidis JP. An empirical evaluation of multifarious outcomes in pharmacogenetics: beta-2 adrenoceptor gene polymorphisms in asthma treatment. Pharmacogenetics Genomics 2006; 16(10):705-711.
48. Clarke M. Standardising outcomes for clinical trials and systematic reviews. Trials 2007; 8:39.
49. Sinha I, Jones L, Smyth RL, Williamson PR. A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children. PLoS Medicine 2008; 5(4):e96.
50. Dusing R, Lottermoser K, Mengden T. Compliance with drug therapy-new answers to an old question. Nephrology, Dialysis, Transplantation 2001; 16(7):1317-1321.